The acquisition will greatly enhance and expand technology solutions platform in the minimally invasive and interventional therapies sectorWAYNE, Pa., Nov. 9, 2023 /PRNewswire/ -- TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, has signed a definitive agreement to acquire Seisa Medical in a deal that significantly extends TekniPlex Healthcare's medical technology solutions platform.

此次收购将大大增强和扩展微创和介入治疗部门的技术解决方案平台，该部门于2023年11月9日/PRNewswire/-TekniPlex Healthcare利用先进的材料科学专业知识帮助提供更好的患者结果，已签署明确协议收购Seisa Medical，这项协议大大扩展了TekniPlex Healthcare的医疗技术解决方案平台。

This acquisition specifically enhances the company's materials science and process technologies for minimally invasive and interventional therapy devices on a global scale..

这项收购在全球范围内专门增强了公司的微创和介入治疗设备材料科学和工艺技术。。

Continue Reading

继续阅读

TekniPlex Healthcare Signs Definitive Purchase Agreement To Acquire Seisa Medical

TekniPlex Healthcare签署明确购买协议以收购Seisa Medical

Post this

发布这个

TekniPlex Healthcare has signed a definitive purchase agreement to acquire Seisa Medical, a full solution, complex manufacturing partner, and leader in AAA stent manufacturing.

TekniPlex Healthcare已签署明确的购买协议，以收购Seisa Medical，一个完整的解决方案，复杂的制造合作伙伴以及AAA支架制造领域的领导者。

TekniPlex Healthcare has signed a definitive purchase agreement to acquire Seisa Medical, a full solution, complex manufacturing partner, and leader in AAA stent manufacturing.

TekniPlex Healthcare已签署明确的购买协议，以收购Seisa Medical，一个完整的解决方案，复杂的制造合作伙伴以及AAA支架制造领域的领导者。

Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.

Seisa位于德克萨斯州埃尔帕索，是一家医疗设备制造商，为产品生命周期的每个阶段提供服务，包括设计和开发，组件制造和最终组装。它在美国，墨西哥和斯洛伐克的四个设施雇用了2000多名人员。

'This is a transformative acquisition for TekniPlex Healthcare, moving us squarely into the CDMO (contract, development, and manufacturing organization) segment of MedTech for medical technologies,' said Chris Qualters, CEO of TekniPlex Healthcare. 'The ability for us to engage with our global customers on new medical technologies by developing engineered materials, co-designing components and assemblies, utilizing advanced process technologies and providing sterile barrier products allows us to truly partner with them from concept all the way to the point of care to help improve patient outcomes..

TekniPlex Healthcare的首席执行官克里斯·夸尔茨（Chris Qualters）说：“这是TekniPlex Healthcare的变革性收购，将我们直接推向MedTech医疗技术的CDMO（合同，开发和制造组织）部门。”通过开发工程材料，共同设计组件和组件，利用先进的工艺技术和提供无菌屏障产品，我们能够与全球客户就新医疗技术进行接触，这使我们能够从概念到始终与他们真正合作。护理有助于改善患者预后。。

'Medical technologies are rapidly evolving to support more minimally invasive procedures and efficient interventional therapies,' said Bryan Wesselmann, Vice President of Sales and Marketing for TekniPlex Healthcare. 'Seisa brings broad capabilities to advance these interventional technologies such as AAA (abdominal aortic aneurysms) stent grafts, thoracic endovascular grafts, mitral heart valves, endovascular procedures and cardiovascular catheter delivery systems.'Julio Chiu, Seisa founder and CEO, said 'our customers count on us to deliver solutions for their most challenging applications.

TekniPlex Healthcare销售和营销副总裁Bryan Wesselmann说：“医疗技术正在迅速发展，以支持更微创的手术和有效的介入治疗。”Seisa带来了广泛的能力来推进这些介入技术，如AAA（腹主动脉瘤）支架移植物，胸血管内移植物，二尖瓣心脏瓣膜，血管内手术和心血管导管输送系统Seisa创始人兼首席执行官Julio Chiu表示：“我们的客户依靠我们为其最具挑战性的应用程序提供解决方案。

I am very confident that they will continue to count on us as TekniPlex Healthcare shares our same commitment to deliver better patient outcomes. We believe the combination of our two organizations will result in one of the most comprehensive value-added CDMO platforms in the industry.'This is the 20th acquisition that TekniPlex has completed in the past decade, supporting its strategy to grow its business through transformative acquisitions and strategic add-ons.

我非常有信心，他们将继续依赖我们，因为TekniPlex Healthcare也有我们同样的承诺，以提供更好的患者结果。我们相信，我们两个组织的结合将成为该行业最全面的增值CDMO平台之一这是TekniPlex在过去十年中完成的第20次收购，支持其通过转型收购和战略附加来发展业务的战略。

The closing of the acquisition is conditioned upon regulatory approval.About Seisa MedicalSeisa Medical is a global full-service contract manufacturer of Class II and Class III medical devices and specialty components, ranging from implantable stents and tubing sets to pediatric and orthopedic-care products.

收购结束取决于监管部门的批准。关于Seisa MedicalSeisa Medical是II类和III类医疗器械和专业部件的全球全方位合同制造商，范围从可植入支架和管道套件到儿科和骨科护理产品。

It serves customers through every stage of the product life cycle, including design and development, component manufacturing, final assembly, and packaging. Founded in 1983 with headquarters in El Paso, Texas, and manufacturing locations in North America and Europe, Seisa offers end-to-end turn-key solutions backed by full regulatory compliance with FDA registration and ISO 13485 compliant operations.

它在产品生命周期的每个阶段为客户提供服务，包括设计和开发，组件制造，最终组装和包装。Seisa成立于1983年，总部设在德克萨斯州埃尔帕索，以及北美和欧洲的制造基地，提供端到端的关键解决方案，并完全遵守FDA注册和符合ISO 13485标准的运营。

The company is a.

公司是a。